Liquid biopsies may identify patients with solid tumors who are recommended for additional tests to determine whether they’re at increased risk for developing myeloid malignancies (cancer that forms ...

In the rapidly changing world of molecular profiling for genetic diseases, cancer researchers are increasingly optimistic about the reality of a simple blood test to monitor and treat solid tumor ...

Putting liquid biopsies on solid ground: Cancer diagnosis from a milliliter of blood. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2022 / 10 / 221012103135.htm ...

A liquid biopsy test used for molecular profiling in patients with solid tumors also identified patients who were at risk for clonal hematopoiesis, which may develop into myeloid blood cancer.

A new blood test from Labcorp could potentially help cancer patients begin the most efficient treatments as early as possible. The Plasma Focus liquid biopsy requires only a standard blood draw to ...

Researchers have found that liquid biopsies, which are increasingly used in the routine care of patients to identify and monitor the progress of cancer, can also detect a disorder of blood cells ...

Blood tests – simple, noninvasive and economically feasible – promise to become the next major milestone in cancer diagnosis. However, most of these tests, dubbed liquid biopsies, are ...